SANGAMO THERAPEUTICS INC (SGMO)

US8006771062 - Common Stock

1.35  +0.05 (+3.85%)

After market: 1.36 +0.01 (+0.74%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
52.77M176.23M111.30M110.70M118.20M
Minority Interest Expense
N/A0.000.000.00100.00K
Operating Expenses
222.17M278.82M312.60M294.00M247.70M
Research and Development
165.44M221.66M249.90M230.80M180.60M
Selling, General, and Administrative Expenses
56.73M57.17M62.70M63.20M67.10M
Operating Income
-169.40M-102.59M-201.30M-183.30M-129.60M
Interest Income/Expense
7.72M11.10M9.40M5.30M8.80M
Non Recurring Items
-22.17M-171.41MN/AN/AN/A
Income Before Taxes
-183.84M-262.90M-191.80M-178.00M-120.80M
Income Tax
86.00K-5.07M400.00K300.00K300.00K
Net Income
-183.93M-257.83M-192.30M-178.30M-121.00M
EBITDA
-163.67M-87.53M-189.20M-173.90M-123.90M
 
Per Share Data
EPS Diluted Total Ops
-0.98-1.48-1.25-1.23-0.90
Non GAAP EPS
-0.75-1.47-1.25-1.24-0.93
 
Statistics
Profit Margin
-348.54%-146.30%-172.78%-161.07%-102.37%
Operating Profit Margin
-321.00%-58.21%-180.86%-165.58%-109.64%

All data in USD

Charts